Retrospective analysis of the safety profile and clinical, radiological and PSA evolution in metastatic castration resistant prostate cancer (MCRPC), chemotherapy naïve patients treated with abiratarone acetate (AA)

Retrospective analysis of the safety profile and clinical, radiological and PSA evolution in metastatic castration resistant prostate cancer (MCRPC), chemotherapy naïve patients treated with abiratarone acetate (AA)

Saved in:
Bibliographic Details
Published in:Reports of practical oncology and radiotherapy Vol. 18; p. S333
Main Authors: Couselo Paniagua, M, López Carrizosa, M, Samper Ots, P, Zapatero Ortuño, J, Jerviz Guía, V, Ibañez Villoslada, C, Saez Garrido, J, Dominguez Morcillo, M, Martin de Miguel, M
Format: Journal Article
Language:English
Published: Elsevier Urban & Partner Sp. z.o.o 01-06-2013
Subjects:
Hematology, Oncology and Palliative Medicine
Radiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1507-1367
2083-4640
DOI:10.1016/j.rpor.2013.03.518